Evidence map›Paper›PMID 30787318›Full record

ArticleScientific reports2019

Brg1 promotes liver regeneration after partial hepatectomy via regulation of cell cycle.

Baocai Wang, Benedikt Kaufmann, Thomas Engleitner, Miao Lu, Carolin Mogler, Victor Olsavszky, Rupert Öllinger, Suyang Zhong, Cyrill Geraud, Zhangjun Cheng and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Melatonin alleviates alcoholic liver diseaseActa pharmaceutica Sinica. B · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Regulation of liver regeneration by prostaglandin ENaunyn-Schmiedeberg's archives of pharmacology · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Baocai WangDepartment of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Benedikt KaufmannDepartment of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Thomas EngleitnerInstitute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Miao LuDepartment of General Surgery, the Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210000, China.
Carolin MoglerInstitute of Pathology, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Victor OlsavszkyDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University and Center of Excellence in Dermatology, Mannheim, 68135, Germany.
Rupert ÖllingerInstitute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Suyang ZhongDepartment of Medicine II, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Cyrill GeraudDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University and Center of Excellence in Dermatology, Mannheim, 68135, Germany.
Zhangjun ChengDepartment of General Surgery, the Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210000, China.
Roland R RadInstitute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Roland M SchmidDepartment of Medicine II, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Helmut FriessDepartment of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
Norbert HüserDepartment of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany.ORCID 0000-0003-1521-1970
Daniel HartmannDepartment of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany. daniel.hartmann@tum.de.
Guido von FiguraDepartment of Medicine II, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, 81675, Germany. gvfigura@tum.de.
TUM Klinikum · DEHeidelberg University · DEZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brahma-related gene 1 (Brg1), a catalytic subunit of the SWItch/Sucrose Non-Fermentable (SWI/SNF) complex, is known to be involved in proliferative cell processes. Liver regeneration is initiated spontaneously after injury and leads to a strong proliferative response. In this study, a hepatocyte-specific Brg1 gene knockout mouse model was used to analyse the role of Brg1 in liver regeneration by performing a 70% partial hepatectomy (PH). After PH, Brg1 was significantly upregulated in wildtype mice. Mice with hepatocyte-specific Brg1 gene knockout showed a significantly lower liver to body weight ratio 48 h post-PH concomitant with a lower hepatocellular proliferation rate compared to wildtype mice. RNA sequencing demonstrated that Brg1 controlled hepatocyte proliferation through the regulation of the p53 pathway and several cell cycle genes. The data of this study reveal a crucial role of Brg1 for liver regeneration by promoting hepatocellular proliferation through modulation of cell cycle genes and, thus, identify Brg1 as potential target for therapeutic approaches.

Indexed as

Cell CycleHepatectomyLiver RegenerationAnimalsCell ProliferationDNA HelicasesLiverMaleMice, KnockoutNuclear ProteinsSignal TransductionTranscription FactorsTumor Suppressor Protein p53DNA HelicasesNuclear ProteinsSmarca4 protein, mouseTranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID30787318
PMCPMC6382836
OpenAlexW2915844574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.